Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study

Oral ketamine for depression: An updated systematic review

(2023) Shakila Meshkat et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings

(2023) Carmen F.M. van Hooijdonk et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Integrating the neurodevelopmental and dopamine hypotheses of schizophrenia and the role of cortical excitation-inhibition balance.

(2022) Oliver D. Howes et al.   BIOLOGICAL PSYCHIATRY

Evaluation of Intraperitoneal [18F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity

(2022) Els F. Halff et al.   Molecular Imaging

1-phenylcyclohexan-1-amine hydrochloride (PCA HCl) alters mesolimbic dopamine system accompanied by neuroplastic changes: A neuropsychopharmacological evaluation in rodents

(2021) Arvie Abiero et al.   NEUROCHEMISTRY INTERNATIONAL

Repeated but not single administration of ketamine prolongs increases of the firing activity of norepinephrine and dopamine neurons

(2021) Chidiebere Michael Iro et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The RESILIENT PHENOTYPE INDUCED BY PROphylactic ketamine exposure during adolescence is mediated by the VTA-NAC pathway.

(2021) Eric M. Parise et al.   BIOLOGICAL PSYCHIATRY

Neuromelanin accumulation in patients with schizophrenia: A systematic review and meta-analysis

(2021) Fumihiko Ueno et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine

(2020) Michelle Kokkinou et al.   MOLECULAR PSYCHIATRY

Enduring effects of adolescent ketamine exposure on cocaine- and sucrose-induced reward in male and female C57BL/6 mice

(2020) Israel Garcia-Carachure et al.   NEUROPSYCHOPHARMACOLOGY

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia

(2020) Susan F. Sonnenschein et al.   Frontiers in Psychiatry

Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia

(2020) Katherine Beck et al.   JAMA Network Open

Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms

(2019) Robert A. McCutcheon et al.   TRENDS IN NEUROSCIENCES

Heterogeneity of striatal dopamine function in schizophrenia: meta-analysis of variance

(2019) Stefan P. Brugger et al.   BIOLOGICAL PSYCHIATRY

Long-lasting effects of repeated ketamine administration in adult and adolescent rats

(2019) M.L. Shawn Bates et al.   BEHAVIOURAL BRAIN RESEARCH

Alterations in cortical interneurons and cognitive function in schizophrenia

(2018) Samuel J. Dienel et al.   NEUROBIOLOGY OF DISEASE

The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention

(2018) Anthony A Grace et al.   SCHIZOPHRENIA BULLETIN

Single cocaine exposure does not alter striatal pre-synaptic dopamine function in mice: an [18 F]-FDOPA PET study

(2017) David R Bonsall et al.   JOURNAL OF NEUROCHEMISTRY

Locomotor sensitization to intermittent ketamine administration is associated with nucleus accumbens plasticity in male and female rats

(2017) C.E. Strong et al.   NEUROPHARMACOLOGY

Sex- and dose-dependent abuse liability of repeated subanesthetic ketamine in rats

(2017) Kristin J. Schoepfer et al.   PHYSIOLOGY & BEHAVIOR

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis

(2017) Robert McCutcheon et al.   SCHIZOPHRENIA BULLETIN

A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia

(2017) Sameer Jauhar et al.   JAMA Psychiatry

Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia

(2015) Mark Slifstein et al.   JAMA Psychiatry

Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study

(2013) Oliver D. Howes et al.   BRAIN

Neuromelanin of the Human Substantia Nigra: An Update

(2013) Fabio A. Zucca et al.   NEUROTOXICITY RESEARCH

In-vivo Measurement of LDOPA Uptake, Dopamine Reserve and Turnover in the Rat Brain Using [18F]FDOPA PET

(2012) Matthew D Walker et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice

(2012) Manavi Chatterjee et al.   NEUROPHARMACOLOGY

Dichotomy of Tyrosine Hydroxylase and Dopamine Regulation between Somatodendritic and Terminal Field Areas of Nigrostriatal and Mesoaccumbens Pathways

(2012) Michael F. Salvatore et al.   PLoS One